NOT-CA-22-135: Notice of Pre-Application Webinar for RFA-CA-22-035, RFA-CA-22-036, and RFA-CA-22-037: "The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers"

Notice of Pre-Application Webinar for RFA-CA-22-035, RFA-CA-22-036, and RFA-CA-22-037: "The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers"

Notice Number:

NOT-CA-22-135

Key Dates

Release Date:

September 28, 2022

Related Announcements

RFA-CA-22-035 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

RFA-CA-22-036 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

RFA-CA-22-037 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Monday, November 7, 2022, from 2:00 - 3:00 PM (ET) for the following Funding Opportunity Announcements (FOAs) for "Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers":

RFA-CA-22-035 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
RFA-CA-22-036 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
RFA-CA-22-037 - NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)

NCI staff members involved in these FOAs will provide orientation to potential applicants by explaining the goals and objectives for the FOAs and answer questions from webinar attendees.

Participation in this webinar, although encouraged, is optional, and is not required for the submission of an application in response to RFA-CA-22-035, RFA-CA-22-036, and RFA-CA-22-037.

Following the webinar, the presentation slides will be posted on https://www.cancer.gov/grants-training/training/funding/early-k99. The webinar will be recorded.

Webinar Information

Webinar Date: Monday, November 7, 2022, 2:00-3:00 PM ET

https://cbiit.webex.com/cbiit/j.php?MTID=maa609f6ee5a92e217cf9affd5fd3aa85
Meeting number: 2311 987 0275
Password: aQW7Nyd74g@

Join by video system
Dial [email protected]
You can also dial 173.243.2.68 and enter the meeting number.

Join by phone
1-650-479-3207 Call-in toll number (US/Canada)

Inquiries

Please direct all inquiries to:

Sergey Radaev, PhD
Cancer Training Branch
National Cancer Institute (NCI)
Telephone: 240-276-5630
Email: [email protected]